Results 171 to 180 of about 385,065 (234)

Platelet-engineered CAR-T cells as adjuvant therapy after cancer surgery. [PDF]

open access: yesProc Natl Acad Sci U S A
Wang Y   +9 more
europepmc   +1 more source

The role of immune checkpoint molecules in cancers. [PDF]

open access: yesFront Immunol
Zhang M   +7 more
europepmc   +1 more source

Adaptive immunotherapeutic paradigms in diffuse midline glioma: integrating epigenetic reprogramming, neuron-glioma interactions, and tumor microenvironment modulation. [PDF]

open access: yesJ Neurooncol
Liu J   +13 more
europepmc   +1 more source

B7-H3: a promising target for immunotherapy in glioma. [PDF]

open access: yesDiscov Oncol
Feng XL, Su G, Jia Q, Wu QH, Zhang ZC.
europepmc   +1 more source

Self-Multimerization of mRNA LNP-Derived Antigen Improves Antibody Responses. [PDF]

open access: yesVaccines (Basel)
Despins CA   +5 more
europepmc   +1 more source

A novel TM4SF4-targeting therapeutic antibody candidate with antitumor activity by blocking IGF1R and CD44 signaling and downregulating PD-L1 and B7-H4. [PDF]

open access: yesTheranostics
Kim RK   +14 more
europepmc   +1 more source

B7-H3 CAR T Cells Are Effective against Ependymomas but Limited by Tumor Size and Immune Response. [PDF]

open access: yesClin Cancer Res
Mehta S   +21 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy